Description
The first FDA approved rapid point-of-care test that detects both HIV-1/2 antibodies and free HIV-1 p24 antigen. This antigen/antibody test (4th generation) has the ability to identify HIV earlier than antibody-only tests (2nd and 3rd generation).1 It enables health care providers to diagnose HIV infection earlier allowing individuals to seek medical care sooner.
CLIA-waived for fingerstick whole blood
INNOVATIVE
It’s the first antigen/antibody rapid point-of-care test that detects both HIV-1/2 antibodies and free HIV-1 p24 antigen on a single test strip.
DEPENDABLE
Built-in quality controls to let you know the test is working.
EFFICIENT
Test in three simple steps with clear results in just 20 minutes.
EARLIER DETECTION
The first antigen/antibody test, with the ability to detect HIV earlier than antibody-only tests.1
FLEXIBLE
Test using whole blood, serum or plasma samples.
RELIABLE
Proved 99.9% overall clinical sensitivity for all sample types.
Specifications:
| Sample Type | Overall Clinical Sensitivity |
Overall Clinical Specificity |
| Fingerstick Whole Blood | 99.9% | 99.8% |
| Venous Whole Blood | 99.9% | 99.7% |
| Serum | 99.9% | 99.6% |
| Plasma | 99.9% | 99.7% |
Reviews
There are no reviews yet.